Literature DB >> 2558488

Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons.

M Mukoyama1, K Yamazaki, T Kikuchi, T Tomita.   

Abstract

A new neurological mutant mouse shows a gracile axonal dystrophy (GAD). The degenerative lesion develops by postnatal day 80, first appearing in the most rostral portion of the gracile fascicles. This lesion then extends caudally to involve the entire gracile fascicles. Many axonal swellings (dystrophies) also appear in the degenerative lesions in proportion to their severity. The clinical findings develop in keeping with these pathological changes, and are characterized by tremor, ataxia and difficulty in moving the hind limbs. These start around day 80, and progress gradually to death about day 150. The lumbar dorsal roots, their spinal root ganglia and peripheral nerves are normal. Electron microscopic study shows dystrophic axons packed with neurofilaments, mitochondria and tubulovesicular structures. These may reflect some stagnation of axonal transport. The distribution of the lesions suggest that the GAD mouse has a central distal axonopathy involving primary sensory neurons of the lumbar dorsal root ganglia.

Entities:  

Mesh:

Year:  1989        PMID: 2558488     DOI: 10.1007/BF00294664

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  NEUROAXONAL DYSTROPHY IN MUCOVISCIDOSIS.

Authors:  J H SUNG
Journal:  J Neuropathol Exp Neurol       Date:  1964-10       Impact factor: 3.685

2.  Infantile neuroaxonal dystrophy.

Authors:  D COWEN; E V OLMSTEAD
Journal:  J Neuropathol Exp Neurol       Date:  1963-04       Impact factor: 3.685

3.  AN UNIQUE TYPE OF AXONAL ALTERATION (so-called axonal dystrophy) as seen in Goll's nucleus of 277 cases of controls. A contribution to the pathology of aging process.

Authors:  K Fujisawa
Journal:  Acta Neuropathol       Date:  1967-05-05       Impact factor: 17.088

4.  Strümpell's familial spastic paraplegia: genetics and neuropathology.

Authors:  W M Behan; M Maia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-01       Impact factor: 10.154

5.  Myeloneuropathy in dogs induced by iodoxyquinoline.

Authors:  J Tateishi; H Ikeda; A Saito; S Kuroda; S Otsuki
Journal:  Neurology       Date:  1972-07       Impact factor: 9.910

6.  Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse.

Authors:  K Yamazaki; N Wakasugi; T Tomita; T Kikuchi; M Mukoyama; K Ando
Journal:  Proc Soc Exp Biol Med       Date:  1988-02

7.  Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.

Authors:  G Baumgartner; M J Gawel; H E Kaeser; C A Pallis; F C Rose; H H Schaumburg; P K Thomas; N H Wadia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-12       Impact factor: 10.154

8.  Hallervorden Spatz disease. Its pathogenesis and place among the axonal dystrophies.

Authors:  O W Sacks; M J Aguilar; W J Borwn
Journal:  Acta Neuropathol       Date:  1966-03-04       Impact factor: 17.088

9.  Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.

Authors:  P S Spencer; H H Schaumburg
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

10.  Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.

Authors:  P S Spencer; H H Schaumburg
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

View more
  18 in total

1.  Proteome analysis of lumbar spinal cord from rats submitted to peripheral lesion during neonatal period.

Authors:  Erich Castro-Dias; André S Vieira; Claudio C Werneck; Francesco Langone; José C Novello; Daniel Martins-de-Souza
Journal:  J Neural Transm (Vienna)       Date:  2010-04-13       Impact factor: 3.575

2.  Fine structural changes of muscle spindles in the gracile axonal dystrophy mutant mouse.

Authors:  A Takagi; K Oda; T Kikuchi; H Kajihara
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

Review 3.  Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.

Authors:  Steven H Graham; Hao Liu
Journal:  Ageing Res Rev       Date:  2016-10-01       Impact factor: 10.895

4.  Sulfatide accumulation in the dystrophic terminals of gracile axonal dystrophy mice: lipid analysis using matrix-assisted laser desorption/ionization imaging mass spectrometry.

Authors:  Sayoko Onishi; Yoshiki Tatsumi; Keiji Wada; Hyun-Jeong Yang; Yuki Sugiura; Mitsutoshi Setou; Hiroo Yoshikawa
Journal:  Med Mol Morphol       Date:  2013-02-16       Impact factor: 2.309

5.  Demyelination and axonal dystrophy in alpha A-crystallin transgenic mice.

Authors:  E P De Rijk; A F Van Rijk; E Van Esch; W W De Jong; P Wesseling; H Bloemendal
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

6.  Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse.

Authors:  T Kikuchi; M Mukoyama; K Yamazaki; H Moriya
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction.

Authors:  Fujun Chen; Yoshie Sugiura; Kalisa Galina Myers; Yun Liu; Weichun Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations.

Authors:  Ibrahim Malik; John Turk; David J Mancuso; Laura Montier; Mary Wohltmann; David F Wozniak; Robert E Schmidt; Richard W Gross; Paul T Kotzbauer
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  Evaluation of blastomere biopsy using a mouse model indicates the potential high risk of neurodegenerative disorders in the offspring.

Authors:  Yang Yu; Jindao Wu; Yong Fan; Zhuo Lv; Xuejiang Guo; Chun Zhao; Rong Zhou; Zhuo Zhang; Fuqiang Wang; Min Xiao; Ling Chen; Hui Zhu; Wen Chen; Min Lin; Jiayin Liu; Zuomin Zhou; Liu Wang; Ran Huo; Qi Zhou; Jiahao Sha
Journal:  Mol Cell Proteomics       Date:  2009-03-11       Impact factor: 5.911

10.  Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.

Authors:  Kaya Bilguvar; Navneet K Tyagi; Cigdem Ozkara; Beyhan Tuysuz; Mehmet Bakircioglu; Murim Choi; Sakir Delil; Ahmet O Caglayan; Jacob F Baranoski; Ozdem Erturk; Cengiz Yalcinkaya; Murat Karacorlu; Alp Dincer; Michele H Johnson; Shrikant Mane; Sreeganga S Chandra; Angeliki Louvi; Titus J Boggon; Richard P Lifton; Arthur L Horwich; Murat Gunel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.